Bruce Levine Speaks on the Progress of CAR T at the 2023 CAR-TCR Summit

Bruce Levine, PhD, the Barbara and Edward Netter Professor in Cancer Gene Therapy, spoke about the progress of CAR T therapy at the 2023 CAR-TCR Summit. In this recorded event, which took place on the six-year anniversary of the first approved CAR-T  Levine, discusses emerging technology trends that might improve CAR-T therapies. Watch it here.

Skip to content